euglycemic

(redirected from euglycaemic)

eu·gly·ce·mic

(yū'glī-sē'mik),
Denoting, characteristic of, or promoting euglycemia.
Synonym(s): normoglycemic

eu·gly·ce·mic

(yū'glī-sē'mik)
Denoting, characteristic of, or promoting euglycemia.
Synonym(s): normoglycemic, euglycaemic.
References in periodicals archive ?
WHO clinical criteria for metabolic syndrome * Insulin resistance, identified by one of the following: * Type 2 diabetes * Impaired fasting glucose * Impaired glucose tolerance * Or, for those with normal fasting glucose levels (<110 mg/dL), glucose uptake below the lowest quartile for background population under investigation under hyperinsulinaemic, euglycaemic conditions Plus any two of the following: * Antihypertensive medication and/or high blood pressure ([greater than or equal to] 140 mmHg systolic or [greater than or equal to] 90 mmHg diastolic) * Plasma triglycerides [greater than or equal to] 150 mg/dL ([greater than or equal to] 1.
The pharmacokinetics (PK) and pharmacodynamics (PD) of LY2963016 insulin glargine and the EU- and US-approved versions of insulin glargine were evaluated in three Phase I, randomized, double-blind, cross-over replicate euglycaemic clamp studies in healthy participants.
Euglycaemic single dose clamp profile of new insulin glargine formulation in subjects with type 1 diabetes is flat and prolonged.
Insulin sensitivity was also assessed using homoeostasis model assessment (HOMA) indices and the euglycaemic hyperinsulinaemic clamp technique.
The gold standard for determining insulin resistance is the hyperinsulinaemic euglycaemic clamp study.
The European Group for the study of Insulin Resistance (EGIR) announced today that the clinical trial recruitment milestone of 1,200 subjects has been reached in the Relationship between Insulin Sensitivity and Cardiovascular disease risk (RISC) study - the largest study using the euglycaemic clamp technique to date to examine whether insulin resistance predicts cardiovascular disease (CVD), as well as future development of type 2 diabetes.
Glucose disposal rates and insulin sensitivity using the hyperinsulinaemic euglycaemic clamp: a comparison of the current data (mean values [+ or -] SD) with comparative data from published studies of other ethnic groups Study / n Age BMI % body Ethnic group (yr) (kg/[m.
The trial was a double blind, placebo controlled study involving 42 patients in three arms, where insulin sensitivity was measured by hyperinsulinemic euglycaemic clamp.
It was reported that two nights of CPAP treatment improved insulin sensitivity as assessed by the hyperinsulinaemic euglycaemic clamp in a group of non-diabetic men with moderate OSA, and the effect was more prominent in non obese patients with a BMI <30 kg/[m.
The impact of tenofovir on insulin sensitivity and lipids has been studied in healthy male volunteers by using hyperinsulinaemic euglycaemic clamping [16].
Previous euglycaemic clamp studies found a linear relationship between the insulin infused and carbohydrate load.
Following a baseline oral glucose tolerance test (OGTT), euglycaemic hyperinsulinaemic clamp, body composition measurements, muscle biopsies, and blood and urine chemistry, subjects were randomised to receive chromium picolinate 500mcg or placebo twice daily for 16 weeks.